MIGUEL BUHAT: Open Payments
NPI 1154937373 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,191 in 43 payments from 13 companies in 2025. Trend: 2023 $929 · 2024 $1,353 · 2025 $1,191
Food & beverage: $1,106Education: $85
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 8 | $409 |
| Amgen Inc. | 9 | $261 |
| Organon LLC | 8 | $122 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| E.R. Squibb & Sons, L.L.C. | 4 | $58 |
| Novartis Pharmaceuticals Corporation | 3 | $54 |
| Arcutis Biotherapeutics, Inc. | 2 | $42 |
| Janssen Biotech, Inc. | 2 | $40 |
| ABBVIE INC. | 2 | $35 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $28 |
Products named: NEMLUVIO, Otezla, DUPIXENT, Sotyktu, Zoryve, TREMFYA, VTAMA, SKYRIZI.
Industry payments across TX — which companies pay providers there.
